ASRS 2024: Real-world safety and efficacy of aflibercept 8 mg in the treatment nAMD
Listen to Deepak Sambhara, MD, present the findings from a real-world case study that measured the safety and efficacy of Aflibercept 8 mg for treating nonexudative AMD at ASRS 2024.
Read More